The Role of Preemptive Infiltration Anesthesia in the Management of Postoperative Pain Following Septoplasty.
Haydar Murat YenerUmur AkinerElif SariZülküf Burak ErdurFirat TevetogluEmine Deniz GözenPublished in: International archives of otorhinolaryngology (2022)
Introduction Septoplasty is one of the most common surgical procedures in rhinology practice. Two major problems encountered after septoplasty are pain and bleeding. Preoperative administration of analgesics before the surgical stimulus, which is the main concept of preemptive analgesia, decreases postoperative pain. Objective The present study was designed to investigate whether preincisional lidocaine infiltration to the subperichondrial area during septoplasty surgery reduced or not postoperative pain and analgesic use. Methods The present prospective, randomized, placebo controlled, double-blind trial was conducted on 64 consecutive patients with nasal septum deviation. Patients were randomly divided into 2 groups; the study group received 2% 20 mg lidocaine/cc ( n = 31), and the control group received 6 cc 0.9% NaCl ( n = 33). A standard questionnaire was given to each patient to mark his or her pain score between 0 and 10 at the 1 st , 3 rd , 6 th , 12 th , and 24 th hours. Results The mean and the range of visual analogue scale (VAS) scores of the patients in the study group at the 1 st , 3 rd , 12 th , and 24 th hours were 4.03 ± 3.08 (0-10); 3.42 ± 2.39 (0-8); 2.97 ± 2.22 (0-8); 2.87 ± 2.61 (0-9); and 1.94 ± 2.06 (0-9) respectively. The mean and the range of VAS scores of the patients in the control group at the 1 st , 3 rd , 12 th , and 24 th hours were 4.12 ± 2.7 (0-10); 3.45 ± 2.4 (0-10); 2.94 ± 2.7 (0-10); 2.79 ± 2.34 (0-10); and 1.5 ± 1.8 (0-6), respectively. The statistical analysis revealed no significant difference among the groups. Conclusion The preemptive local anesthetic administration to the incision area and under the mucoperichondrial flap before septoplasty does not decrease the level of postoperative pain.
Keyphrases
- postoperative pain
- end stage renal disease
- double blind
- placebo controlled
- newly diagnosed
- chronic kidney disease
- ejection fraction
- phase iii
- clinical trial
- prognostic factors
- primary care
- randomized controlled trial
- neuropathic pain
- healthcare
- open label
- phase ii
- spinal cord injury
- peritoneal dialysis
- acute coronary syndrome
- study protocol
- pain management
- spinal cord
- patient reported
- patient reported outcomes
- cross sectional
- percutaneous coronary intervention
- coronary artery disease